UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044095
Receipt number R000050354
Scientific Title Detection of unshared-HLA restricted T lymphocytes in HLA mismatched hematopoietic stem cell transplantation
Date of disclosure of the study information 2021/05/05
Last modified on 2021/05/02 16:04:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Detection of unshared-HLA restricted T lymphocytes in HLA mismatched hematopoietic stem cell transplantation

Acronym

Detection of unshared-HLA restricted T lymphocytes

Scientific Title

Detection of unshared-HLA restricted T lymphocytes in HLA mismatched hematopoietic stem cell transplantation

Scientific Title:Acronym

Detection of unshared-HLA restricted T lymphocytes

Region

Japan


Condition

Condition

Patients with hematologic disorder who undergoing HLA mismatched hematopoietic stem cell transplantation

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To detect donor-derived T lymphocytes restricted patient's HLA, which is a proof of thymic function in human adults

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To detect T lymphocytes restricted to patient's or donor's unique HLA

Key secondary outcomes

identification of T cell subsets of the T cells
functional test of the T cells


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who received HLA mismatched hematopoietic stem cell transplantation (haploidentical, 2-HLA-haplotype-mismatched, spousal, cord blood, marrow bank)

Key exclusion criteria

N/A

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Ikegame

Organization

Hyogo College of Medicine

Division name

Hematology

Zip code

663-8501

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

TEL

+81798456886

Email

kame@hyo-med.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Ikegame

Organization

Hyogo College of Medicine

Division name

Hematology

Zip code

663-8501

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

TEL

+81798456886

Homepage URL


Email

kame@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Helth and Labour Science Research Grants for Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan, Grants-in aid for Scientific Research (21K08408)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Hyogo College of Medicine

Address

1-1 Mukogawa-cho, Nishinomiya City, Hyogo

Tel

+81798456886

Email

kame@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 05 Month 02 Day

Date of IRB


Anticipated trial start date

2021 Year 06 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To detect patient's or donor's unique HLA-restricted T lymphocytes in patients' blood who underwent HLA mismatched hematopoietic stem cell transplantation using HLA-A*24:02 CMV-pp65341-349tetramer (Medical & Biological Laboratories, Nagoya)


Management information

Registered date

2021 Year 05 Month 02 Day

Last modified on

2021 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050354


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name